Pharmaceutical compositions for treating or preventing cancer
OwnerKarin Molling, Jovan Pavlovic +1inventors
InventorsKarin Molling, Jovan Pavlovic, Michael Nawrath
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical or vaccine composition comprising a nucleic acid molecule encoding a tumor-associated antigen and at least one peptide comprising a region corresponding to a putative cytotoxic T cell, helper T cell or B cell epitope of a tumor-associated antigen and/or cells pulsed with such peptides, optionally in combination with a pharmaceutically acceptable carrier. Such pharmaceutical compositions can be used for the treatment of cancer or for the vaccination against cancer.
Claims14
A pharmaceutical composition comprising a nucleic acid molecule encoding a tumor-associated antigen and at least one peptide comprising a region corresponding to a putative cytotoxic T cell, helper T cell or B cell epitope of a tumor-associated antigen and/or cells pulsed with such peptide(s).
Use of a nucleic acid molecule encoding a tumor-associated antigen in combination with at least one peptide comprising a region corresponding to a putative cytotoxic T cell, helper T cell or B cell epitope of a tumor-associated antigen and/or cells pulsed in vitro with said at least one peptide for the preparation of a pharmaceutical composition for the treatment or prevention of cancer.
Dependencies are inferred from the claim text.